Thursday, October 13th 2022
08:30am - 8:55am (CET)
Opening ceremony
- Maryvonne Hiance President of HealthTech For Care
- Additionnal Speakers to be confirmed
09:00am - 9:50am
Build tomorrow’s healthcare for all European citizen
- Christian Pierret Former Minister of Industry (moderator)
- Michel Goldman President I3h Institute at the Free University of Brussels
- Additionnal Speakers to be confirmed
09:50am - 10:05am
Break & Networking
10:05am - 10:55am
Funding Innovation: is there a creative approach smarter than pouring money?
- Philippe Lopes-Fernandes Executive Vice President, Chief Business Officer, Member of the Executive Committee, at Ipsen (moderator)
- Laurent Arthaud Managing Director for Investments in Lifesciences, Ecotechnologies and French Tech at Bpifrance
- Iordanis Arzimanoglou EIC Programme Manager for Health and Biotechnology
- Jean-Marc Bourez CEO ad interim at EIT Health, Managing Director EIT Health France
- Enric Claverol-Tinturé EIC Programme Manager for medical technologies and medical devices
- Johanna Michielin Head at Biolabs France
11:00am - 12:10pm
Age-related diseases, a continuum from birth to death
- Antoni Montserrat Vice President at the Luxembourg National Committee for rare diseases (moderator)
- André Baruchel Professor of Paediatrics - Head of Department at APHP, University of Paris
- Ross Jeggo Global Head of Neuroscience and Immuno-inflammation Therapeutic Area at Servier
- Carlos Buesa Founder and Chairman at Oryzon
- Walid Kamoun Vice President, Global Head of R&D Oncology at Servier
- Jean Mariani Professor Emeritus at Sorbonne University, Director of the Institute of Longevity
- Additionnal Speakers to be confirmed
12:10pm - 01:20pm
Lunch & Networking
01:20pm - 01:40pm
R&D collaboration led by Bristol Myers Squibb
- Additionnal Speakers to be confirmed
01:45pm - 02:25pm
Prospective scenario of the health system in 2032 and perspective at European level
- Additionnal Speakers to be confirmed
02:30pm - 03:25pm
Covid wake up call on health innovation investments - – Opportunities and turbulence
- Cédric Moreau Partner at Sofinnova Partners (moderator)
- Yann Le Flohic Country Director Life Sciences Acceleration Alliance,Co-founder Allison+Partners PR France
- Elena Coluccelli-Guérin Managing Partner, Healthcare M&A, focus on mid cap at Rothschild & Co
- Aniz Girach Ophthalmologist, Board Director, Chief Medical Officer at ProQR Therapeutics
03:25pm - 03:45pm
Break & Networking
03:45pm - 04:10pm
TR Dechert
- Sophie Pelé Lawyer at Dechert LLP
- Edward Kliphuis Partner at Sofinnova Partners
- Simon Turner Partner at Sofinnova Partners
- Alain Decombe Deputy Chair for International Operations, Paris Managing Partner at Dechert LLP
04:15pm - 05:10pm
How AI is revolutionizing the patient-doctor relationship
- Emmanuelle Trombe Lawyer and Partner at McDermott Will & Emery (moderator)
- Patrick Boisseau Director General, Strategic Initiatives at MedTech Europe
- Karine Samama Healthcare and life sciences strategy and partnerships executive at Microsoft
- Koen Cobbaert Senior Manager - Quality, Standards & Regulations at Philips
- Katja Niedermeier Specialist in general medicine, diabetologist at Praxis
- Clara Moschetti Innovation Projects Manager at StatupInside and AI For Health
05:15pm - 06:15pm
Translational microbiome medicine to treat serious oncology and infectious diseases
- Isabelle de Cremoux CEO and Managing Partner at Seventure Partners (moderator)
- Hervé Affagard Founder and CEO at MaaT Pharma
- Per Falk President at Ferring Pharmaceuticals
- Mohamad Mohty Professor of Hematology at Sorbonne University, and head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital
- Mike Romanos CEO at Microbiotica
- Hassane Zarour Professor of Medicine, Immunology and Dermatology, University of Pittsburgh
06:15pm - 06:30pm
Break & Networking
06:30pm - 06:45pm
Keynote Jeito Capital
- Sabine Dandiguian Managing Partner at Jeito
06:50pm - 07:30pm
Institutional
- Institutional to be confirmed
Friday, October 14th 2022
08:45am - 9:25am (CET)
In vitro diagnostics industry in Europe : at the heart of patient’s care
- Marie Anson PhD in Immunology, Project manager at EIT Health
- Gérald Ulrich CEO of Quantamatrix Europe
- Additionnal Speakers to be confirmed
09:30am - 10:05am
IPO testimonials & expectations
- Franck Grimaud President & CBO at VALNEVA
- Michael Kloss CEO and Co-founder of eureKING
- Camille Leca Head of Listing France, Portugal & Spain at Euronext
- Jean Luc Vandebroek Chief Financial Officer, IR and Communication at Hyloris Pharmaceuticals
10:05am - 10:15am
Break & Networking
10:15am - 11:05am
Matching the required talents for a sustainable development: constraints and opportunities!
- Frederik Alberchtsen Consultant at Russell Reynolds Associates (moderator)
- Claude Bertrand Executive Vice President R&D at Servier
- Elsy Boglioli Hofman Founder and CEO at Bio-Up
- Marie Catoire General Secretary at TreeFrog Therapeutics
- Bernard Gilly CEO at GenSight Biologics
- Vanessa Malier Managing Partner at Kurma Partners
11:10am - 12:05pm
Impact of mRNA application in innovative drugs with the support of adapted manufacturing settings (In the memory of François Gros)
- Sylvain Gariel Co-founder and COO of DNA Script
- Regis Gervier Global Head, mRNA Center of Excellence at Sanofi
- Philippe Kourilsky Professor Emeritus at Collège de France
- Marcel Hollenstein Group leader at Pasteur Institute
- Additional Speakers to be confirmed
12:05pm - 01:00pm
Lunch & Networking
01:00pm - 01:55pm
Closing the gap in Women's Health : we need to be the change
- Elsy Boglioli Hofman Founder and CEO at Bio-Up (moderator)
- Bianca Coulter CEO at Coulter Partners
- Gonzague Issenmann Executive Chairman and CEO at Womed
- Marieta Jiménez Senior Vice President Europe at Merck Healthcare
- Jenny Yip Managing Partner at Adjuvant Capital
- Marcel van Duin VP, Head of External Innovation & Emerging Science at Organon
02:00pm - 02:55pm
Digital innovation tools empowering patients in collaboration with healthtech, pharma and investors
- Erik Tambuyzer President at ABConsult (moderator)
- Alain Herrera CMO at Phost’in Therapeutics
- Uroš Bogdanović Attorney at law at ANDRIĆ Attorneys-at-law, IDF Young Leader in Diabetes
- Anaïs Le Corvec Co-Founder at Cliclab Transformative Agent
- Marion Soto VP Business Development at Ariana Pharma
- Jenny Yip Managing Partner at Adjuvant Capital
02:55pm - 03:05pm
Break & Networking
03:05pm - 03:45pm
Social impact of an effective North Atlantic Bridge for long-term innovation
- Pierre Courteille CCO & VP Business Development at Abivax (Moderator)
- Gabriela Apiou Director of Strategic Alliance of Massachusetts General Hospital Research Institute
- Additional Speakers to be confirmed
03:50pm - 04:30pm
Closing Ceremony with Institutional
- Institutional to be confirmed
04:30pm - 06:00pm
Networking